Boulanger M - Search Results

1

General pharmacology of S 15261, a new concept for treatment of diabetes.

Duhault J, Berger S, Boulanger M, Della Zuana O, Lacour F, Wierzbicki M. Duhault J, et al. Among authors: boulanger m. Arzneimittelforschung. 1998 Jul;48(7):734-44. Arzneimittelforschung. 1998. PMID: 9706374

2

S15261, a new compound for the treatment of the insulin resistance syndrome.

Duhault J, Lacour F, Boulanger M, Della-Zuana O, Ravel D, Wierzbicki M, Espinal J. Duhault J, et al. Among authors: boulanger m. Diabetologia. 1994 Oct;37(10):969-75. doi: 10.1007/BF00400459. Diabetologia. 1994. PMID: 7851691

3

Preparation and pharmacological profile of 2-trifluoromethyl-benzo(8,9)-1,3-diaza-spiro (4,6)-undeca-2,8-diene and its enantiomers as new anti-obesity agents.

Boussard MF, Guette JP, Wierzbicki M, Beal P, Fournier J, Boulanger M, Della-Zuana O, Duhault J. Boussard MF, et al. Among authors: boulanger m. Arzneimittelforschung. 2000 Dec;50(12):1084-92. doi: 10.1055/s-0031-1300343. Arzneimittelforschung. 2000. PMID: 11190773

4

Pharmacological properties of a new antiasthmatic xanthine derivative devoid of central stimulatory activity.

Duhault J, Boulanger M, Lonchampt M, Tisserand F, Holstorp S, Saint-Romas G, Pennel L, Regnier G. Duhault J, et al. Among authors: boulanger m. Arzneimittelforschung. 1987 Dec;37(12):1353-62. Arzneimittelforschung. 1987. PMID: 2835053

5

Synthesis of 1,2-diacyl-3-nicotinoyl glycerol derivatives and evaluation of their acute effects on plasma lipids in the rat.

Cordi A, Lacoste JM, Duhault J, Espinal J, Boulanger M, Broux O, Husson B, Volland JP, Mahieu JP. Cordi A, et al. Among authors: boulanger m. Arzneimittelforschung. 1995 Sep;45(9):997-1001. Arzneimittelforschung. 1995. PMID: 7488322

6

Effect of aging and drug-induced weight reduction on rat vascular reactivity.

Feletou M, Moreau N, Boulanger M, Duhault J. Feletou M, et al. Among authors: boulanger m. J Cardiovasc Pharmacol. 1993 Jan;21(1):120-7. doi: 10.1097/00005344-199301000-00018. J Cardiovasc Pharmacol. 1993. PMID: 7678666

7

Euglycaemic and biological activities of novel thiazolidine-2,4-dione derivatives.

de Nanteuil G, Herve Y, Duhault J, Espinal J, Boulanger M, Ravel D. de Nanteuil G, et al. Among authors: boulanger m. Arzneimittelforschung. 1995 Nov;45(11):1176-81. Arzneimittelforschung. 1995. PMID: 8929235

8

Lack of insulin resistance in the Lyon hypertensive rat.

Boulanger M, Duhault J, Broux O, Bataillard A, Sassard J. Boulanger M, et al. Fundam Clin Pharmacol. 1997;11(6):546-9. doi: 10.1111/j.1472-8206.1997.tb00859.x. Fundam Clin Pharmacol. 1997. PMID: 9444522

9

Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?

Duhault J, Boulanger M, Chamorro S, Boutin JA, Della Zuana O, Douillet E, Fauchère JL, Félétou M, Germain M, Husson B, Vega AM, Renard P, Tisserand F. Duhault J, et al. Among authors: boulanger m. Can J Physiol Pharmacol. 2000 Feb;78(2):173-85. Can J Physiol Pharmacol. 2000. PMID: 10737680

10

Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine.

Duhault J, Boulanger M, Voisin C, Malen C, Schmitt H. Duhault J, et al. Among authors: boulanger m. Arzneimittelforschung. 1975 Nov;25(11):1758-62. Arzneimittelforschung. 1975. PMID: 128366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

420 results

Search Page

Filters